XML 13 R4.htm IDEA: XBRL DOCUMENT v3.23.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Revenue:        
Revenue $ 116,920 $ 84,151 $ 226,030 $ 155,084
Cost of sales 52,379 28,675 91,064 50,392
Gross profit 64,541 55,476 134,966 104,692
Operating expenses:        
Research and development 14,571 10,596 27,831 20,318
Sales, general and administrative 87,287 72,668 178,549 142,139
Litigation-related expenses 6,908 5,495 10,100 13,027
Amortization of acquired intangible assets 3,705 2,177 6,588 4,407
Transaction-related expenses 1,900   1,900 120
Restructuring expenses 29 289 204 1,659
Total operating expenses 114,400 91,225 225,172 181,670
Operating loss (49,859) (35,749) (90,206) (76,978)
Interest expense and other income, net:        
Interest expense, net (3,892) (1,435) (7,766) (2,891)
Other income, net 2,324 67 3,030 37
Total interest expense and other income, net (1,568) (1,368) (4,736) (2,854)
Net loss before taxes (51,427) (37,117) (94,942) (79,832)
Income tax benefit (50) (16) (36) (115)
Net loss $ (51,377) $ (37,101) $ (94,906) $ (79,717)
Net loss per share, basic $ (0.43) $ (0.36) $ (0.83) $ (0.79)
Net loss per share, diluted $ (0.43) $ (0.36) $ (0.83) $ (0.79)
Weighted average shares outstanding, basic 118,719 102,849 114,260 101,422
Weighted average shares outstanding, diluted 118,719 102,849 114,260 101,422
Products and Services        
Revenue:        
Revenue $ 116,920 $ 84,151 $ 226,030 $ 155,069
International Supply Agreement        
Revenue:        
Revenue       $ 15